Full-Time
Remote patient monitoring for cancer care
€50k - €65k/yr
Toulouse, France + 2 more
More locations: Marcy-l'Étoile, France | Marseille, France
In Person
Resilience Care offers digital health tools for cancer care, combining a remote patient monitoring platform for clinicians with a patient mobile app. The system collects health data remotely to track treatment, side effects, and adherence, while the app helps patients manage daily life and stay connected to their care team. It adapts to any cancer type or treatment and is used across private and public facilities, serving thousands of patients. The goal is to make cancer care more human and coordinated, improving quality of life, adherence, and survival through personalized support and ongoing feedback from patients and caregivers.
Company Size
201-500
Company Stage
Series B
Total Funding
$74.5M
Headquarters
Paris, France
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
People at Resilience Care who can refer or advise you
Flexible Work Hours
Remote Work Options
Health Insurance
Wellness Program
Resilience Care, a digital oncology platform co-founded with Gustave Roussy Institute, has announced its expansion into the United States after establishing operations across 200 European clinical centres supporting over 35,000 patients. The company has appointed Greg Orr, former COO of Jasper Health, as General Manager for the US market. The platform addresses the "between-visit blind spot" in cancer care through real-time symptom tracking and adaptive treatment pathways. In Europe, the system has driven a four- to five-fold increase in nursing capacity whilst maintaining an 85% patient adherence rate after one year of use. Research shows the platform reduces hospitalisations by up to 38% and decreases severe treatment-related toxicities by 25%. The company has assembled a US advisory board including Eddie Martucci of Akili Interactive and former Merck oncology executive Jill DeSimone.
Resilience, a Paris-based healthtech startup, has secured €25 million in funding to expand its cancer patient monitoring solutions both domestically and internationally. The company, which operates in over 90 hospitals, aims to increase its presence in Belgium and Germany. The funding round was led by Red River West and Picus Capital, with participation from Cathay Innovation, Singular, and Seaya Ventures. Resilience's remote monitoring platform is the first oncology-related device reimbursed by France's national social security.
Resilience raises $25M to expand remote oncology patient monitoring.
Resilience, a startup specializing in medical telemonitoring for oncology patients, has raised $25 million in a Series B funding round led by Picus Capital and Red River West, with participation from Cathay Innovation, Singular, and Seaya Ventures. This funding aims to support its expansion in Belgium and Germany. Since its inception in February 2021, Resilience has raised €5 million in seed funding and €40 million in Series A. The company serves 10,000 patients across 90 healthcare facilities.
The fresh funding adds to the €45m France-based Resilience had previously raised, since launching in 2021.